160 related articles for article (PubMed ID: 6096717)
21. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.
Dalgleish AG; Beverley PC; Clapham PR; Crawford DH; Greaves MF; Weiss RA
Nature; 1984 Dec 20-1985 Jan 2; 312(5996):763-7. PubMed ID: 6096719
[TBL] [Abstract][Full Text] [Related]
22. Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS.
Hahn BH; Shaw GM; Taylor ME; Redfield RR; Markham PD; Salahuddin SZ; Wong-Staal F; Gallo RC; Parks ES; Parks WP
Science; 1986 Jun; 232(4757):1548-53. PubMed ID: 3012778
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of human T-lymphotropic leukemia virus type III associated with the acquired immunodeficiency syndrome.
Wong-Staal F; Hahn BH; Shaw GM; Arya SK; Harper M; Gonda M; Gilden R; Ratner L; Starcich B; Okamoto T
Princess Takamatsu Symp; 1984; 15():291-300. PubMed ID: 6100646
[TBL] [Abstract][Full Text] [Related]
24. Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2).
Sanchez-Pescador R; Power MD; Barr PJ; Steimer KS; Stempien MM; Brown-Shimer SL; Gee WW; Renard A; Randolph A; Levy JA
Science; 1985 Feb; 227(4686):484-92. PubMed ID: 2578227
[TBL] [Abstract][Full Text] [Related]
25. [AIDS physiopathology and epidemiology of the infection with the LAV virus].
Gluckman JC
Rev Epidemiol Sante Publique; 1986; 34(2):112-7. PubMed ID: 3016830
[TBL] [Abstract][Full Text] [Related]
26. [LAV type II: a second retrovirus associated with AIDS in West Africa].
Clavel F; Brun-Vézinet F; Guétard D; Chamaret S; Laurent A; Rouzioux C; Rey M; Katlama C; Rey F; Champelinaud JL
C R Acad Sci III; 1986; 302(13):485-8. PubMed ID: 3013382
[TBL] [Abstract][Full Text] [Related]
27. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule.
McDougal JS; Kennedy MS; Sligh JM; Cort SP; Mawle A; Nicholson JK
Science; 1986 Jan; 231(4736):382-5. PubMed ID: 3001934
[TBL] [Abstract][Full Text] [Related]
28. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
[TBL] [Abstract][Full Text] [Related]
29. Homology of genome of AIDS-associated virus with genomes of human T-cell leukemia viruses.
Arya SK; Gallo RC; Hahn BH; Shaw GM; Popovic M; Salahuddin SZ; Wong-Staal F
Science; 1984 Aug; 225(4665):927-30. PubMed ID: 6089333
[TBL] [Abstract][Full Text] [Related]
30. Molecular cloning and polymorphism of the human immune deficiency virus type 2.
Clavel F; Guyader M; Guétard D; Sallé M; Montagnier L; Alizon M
Nature; 1986 Dec 18-31; 324(6098):691-5. PubMed ID: 3025743
[TBL] [Abstract][Full Text] [Related]
31. Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome.
Fultz PN; McClure HM; Swenson RB; McGrath CR; Brodie A; Getchell JP; Jensen FC; Anderson DC; Broderson JR; Francis DP
J Virol; 1986 Apr; 58(1):116-24. PubMed ID: 3005641
[TBL] [Abstract][Full Text] [Related]
32. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
Mitsuya H; Weinhold KJ; Furman PA; St Clair MH; Lehrman SN; Gallo RC; Bolognesi D; Barry DW; Broder S
Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7096-100. PubMed ID: 2413459
[TBL] [Abstract][Full Text] [Related]
33. Etiology of AIDS: biological and biochemical characteristics of HTLV-III.
Markham PD; Shaw GM; Salahuddin SZ; Hahn B; Sarngadharan MG; Gallo RC
Adv Exp Med Biol; 1985; 187():13-34. PubMed ID: 2994417
[TBL] [Abstract][Full Text] [Related]
34. Immunopathogenesis of the acquired immunodeficiency syndrome.
Bowen DL; Lane HC; Fauci AS
Ann Intern Med; 1985 Nov; 103(5):704-9. PubMed ID: 2996403
[TBL] [Abstract][Full Text] [Related]
35. Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines.
Montagnier L; Gruest J; Chamaret S; Dauguet C; Axler C; Guétard D; Nugeyre MT; Barré-Sinoussi F; Chermann JC; Brunet JB
Science; 1984 Jul; 225(4657):63-6. PubMed ID: 6328661
[TBL] [Abstract][Full Text] [Related]
36. Genetic analysis of a new subgroup of human and simian T-lymphotropic retroviruses: HTLV-IV, LAV-2, SBL-6669, and STLV-IIIAGM.
Franchini G; Collalti E; Arya SK; Fenyö EM; Biberfeld G; Zagury JF; Kanki PJ; Wong-Staal F; Gallo RC
AIDS Res Hum Retroviruses; 1987; 3(1):11-7. PubMed ID: 3040052
[TBL] [Abstract][Full Text] [Related]
37. Molecular evolution and phylogeny of the human AIDS viruses LAV, HTLV-III, and ARV.
Yokoyama S; Gojobori T
J Mol Evol; 1987; 24(4):330-6. PubMed ID: 3110425
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome.
Shaw GM; Hahn BH; Arya SK; Groopman JE; Gallo RC; Wong-Staal F
Science; 1984 Dec; 226(4679):1165-71. PubMed ID: 6095449
[TBL] [Abstract][Full Text] [Related]
39. [Molecular biology of human T-lymphotropic retroviruses (HTLV)].
Dorner F; Barrett PN; Schmidt BL; Bodemer W
Wien Med Wochenschr; 1986 Apr; 136(7-8):181-8. PubMed ID: 2425498
[TBL] [Abstract][Full Text] [Related]
40. Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations.
Ragni MV; Lewis JH; Bracken M; Toth R; Stokes J; Steffensen DO
Transfusion; 1986; 26(3):299-301. PubMed ID: 3010516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
